Literature DB >> 25015688

Anxiety sensitivity as an amplifier of subjective and behavioral tobacco abstinence effects.

Michael J Zvolensky1, Samantha G Farris2, Casey R Guillot3, Adam M Leventhal4.   

Abstract

BACKGROUND: Anxiety sensitivity, a transdiagnostic cognitive vulnerability factor described as an amplifier of negative emotional states, is implicated in the maintenance of cigarette smoking and cessation difficulties. The current study aimed to examine the role of anxiety sensitivity in predicting abstinence-induced changes in nicotine withdrawal, smoking urges and smoking behavior during an experimental relapse analogue task (RAT).
METHOD: Participants were 258 non-treatment seeking smokers (M [SD] age=44.0 [10.73]; 69.8% male). Participants attended two counterbalanced experimental sessions including smoking deprivation (16 h of smoking abstinence) and smoking as usual. The Minnesota Nicotine Withdrawal Scale (MNWS) and Brief Questionnaire of Smoking Urges (QSU) were completed at each session in addition to the RAT. Hierarchical regressions were conducted to examine the predictive impact of anxiety sensitivity on withdrawal and urges during smoking deprivation. Follow-up mediational analyses were conducted to examine whether abstinence-induced withdrawal and urges mediated responding during the RAT.
RESULTS: Anxiety sensitivity amplified the effects of experimentally manipulated acute abstinence on subjective nicotine withdrawal symptoms and smoking urges. Additionally, higher levels of anxiety sensitivity indirectly predicted shorter latency to smoking initiation after deprivation during the RAT through the effects of greater abstinence-induced nicotine withdrawal and smoking urges. Anxiety sensitivity was unrelated to increased smoking during the RAT, although this may be partially attributed to the type of laboratory assessment employed.
CONCLUSIONS: Elevated anxiety sensitivity appears to impact initiation of smoking after nicotine deprivation through the effects of abstinence-induced withdrawal and smoking urges.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety sensitivity; Nicotine withdrawal; Relapse analogue task; Smoking urges

Mesh:

Year:  2014        PMID: 25015688      PMCID: PMC4127105          DOI: 10.1016/j.drugalcdep.2014.06.023

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  53 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse.

Authors:  Chad J Gwaltney; Saul Shiffman; Mark H Balabanis; Jean A Paty
Journal:  J Abnorm Psychol       Date:  2005-11

3.  Incremental validity of anxiety sensitivity in terms of motivation to quit, reasons for quitting, and barriers to quitting among community-recruited daily smokers.

Authors:  Michael J Zvolensky; Anka A Vujanovic; Marcel O Bonn Miller; Amit Bernstein; Andrew R Yartz; Kristin L Gregor; Alison C McLeish; Erin C Marshall; Laura E Gibson
Journal:  Nicotine Tob Res       Date:  2007-09       Impact factor: 4.244

4.  Reactivity to negative affect in smokers: the role of implicit associations and distress tolerance in smoking cessation.

Authors:  Amy Cameron; Kathleen Palm Reed; Andrew Ninnemann
Journal:  Addict Behav       Date:  2013-08-20       Impact factor: 3.913

5.  Nicotine and food deprivation decrease the ability to resist smoking.

Authors:  Robert F Leeman; Stephanie S O'Malley; Marney A White; Sherry A McKee
Journal:  Psychopharmacology (Berl)       Date:  2010-06-29       Impact factor: 4.530

6.  Anxiety sensitivity and smoking motives and outcome expectancies among adult daily smokers: replication and extension.

Authors:  Teresa M Leyro; Michael J Zvolensky; Anka A Vujanovic; Amit Bernstein
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

7.  Mental disorders and cigarette use among adults in the United States.

Authors:  Renee D Goodwin; Michael J Zvolensky; Katherine M Keyes; Deborah S Hasin
Journal:  Am J Addict       Date:  2012 Sep-Oct

8.  Smoking behaviors across anxiety disorders.

Authors:  Randi E McCabe; Susan M Chudzik; Martin M Antony; Lisa Young; Richard P Swinson; Michael J Zolvensky
Journal:  J Anxiety Disord       Date:  2004

9.  Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in nonclinical subjects.

Authors:  R M Rapee; L Medoro
Journal:  J Abnorm Psychol       Date:  1994-11

10.  Depression, anxiety, and smoking initiation: a prospective study over 3 years.

Authors:  G C Patton; J B Carlin; C Coffey; R Wolfe; M Hibbert; G Bowes
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

View more
  18 in total

1.  Anxiety sensitivity in smokers with indicators of cardiovascular disease.

Authors:  Samantha G Farris; Ana M Abrantes
Journal:  Psychol Health Med       Date:  2017-03-07       Impact factor: 2.423

2.  Early onset tobacco cigarette smokers exhibit deficits in response inhibition and sustained attention.

Authors:  Yasmin Mashhoon; Jennifer Betts; Stacey L Farmer; Scott E Lukas
Journal:  Drug Alcohol Depend       Date:  2018-01-12       Impact factor: 4.492

3.  A prospective investigation of the synergistic effect of change in anxiety sensitivity and dysphoria on tobacco withdrawal.

Authors:  Jafar Bakhshaie; Paulina A Kulesz; Lorra Garey; Kirsten J Langdon; Michael S Businelle; Adam M Leventhal; Matthew W Gallagher; Norman B Schmidt; Kara Manning; Renee Goodwin; Michael J Zvolensky
Journal:  J Consult Clin Psychol       Date:  2017-11-27

4.  Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.

Authors:  Jasper A J Smits; Michael J Zvolensky; Michael W Otto; Megan E Piper; Scarlett O Baird; Brooke Y Kauffman; Eunjung Lee-Furman; Noura Alavi; Christina D Dutcher; Santiago Papini; Benjamin Rosenfield; David Rosenfield
Journal:  Drug Alcohol Depend       Date:  2020-01-22       Impact factor: 4.492

5.  Smoking-specific experiential avoidance cognition: explanatory relevance to pre- and post-cessation nicotine withdrawal, craving, and negative affect.

Authors:  Samantha G Farris; Michael J Zvolensky; Norman B Schmidt
Journal:  Addict Behav       Date:  2014-08-06       Impact factor: 3.913

6.  The roles of sex, anxious reactivity to bodily arousal, and anxiety sensitivity in coping motives for cigarette smoking among adolescents.

Authors:  Sarah A Bilsky; Matthew T Feldner; Ashley A Knapp; Sasha M Rojas; Ellen W Leen-Feldner
Journal:  Exp Clin Psychopharmacol       Date:  2016-04-07       Impact factor: 3.157

7.  Anxiety sensitivity and pre-cessation smoking processes: testing the independent and combined mediating effects of negative affect-reduction expectancies and motives.

Authors:  Samantha G Farris; Adam M Leventhal; Norman B Schmidt; Michael J Zvolensky
Journal:  J Stud Alcohol Drugs       Date:  2015-03       Impact factor: 2.582

8.  Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and problems in treatment-seeking cigarette smokers.

Authors:  Casey R Guillot; Heidemarie Blumenthal; Michael J Zvolensky; Norman B Schmidt
Journal:  Addict Behav       Date:  2018-03-08       Impact factor: 3.913

9.  Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.

Authors:  R Kathryn McHugh; Victoria R Votaw; Olivera Bogunovic; Sterling L Karakula; Margaret L Griffin; Roger D Weiss
Journal:  Addict Behav       Date:  2016-08-18       Impact factor: 3.913

10.  BDNF Val66Met Polymorphism as a Moderator of Exercise Enhancement of Smoking Cessation Treatment in Anxiety Vulnerable Adults.

Authors:  Jasper A J Smits; Mark B Powers; David Rosenfield; Michael J Zvolensky; Jolene Jacquart; Michelle L Davis; Christopher G Beevers; Bess H Marcus; Timothy S Church; Michael W Otto
Journal:  Ment Health Phys Act       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.